Financhill
Back

Perspective Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52

CATX
Perspective Therapeutics, Inc.

Last Price:
$2.7400
Seasonality Move:
32.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Perspective Therapeutics, Inc. Stock Forecast

  • Is Perspective Therapeutics, Inc. Stock Undervalued?
    The current Perspective Therapeutics, Inc. [CATX] share price is $2.7500. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics, Inc. Stock Rating

Data Unavailable

Perspective Therapeutics, Inc. Stock Price History

Is CATX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
5.3881
52-Week Low:
1.6000

Prediction Charts

Market Cap:
204.4M
Price in USD:
2.7500
Volume:
969.7K
Beta:
-73.6637

Technical Analysis

SMA50:
2.7560
SMA100:
3.1379
SMA200:
3.0097
52-Wk Change:
-3.17%

Stock Predictions

  • Is Perspective Therapeutics, Inc. stock public?
    Yes, Perspective Therapeutics, Inc. is a publicly traded company.
  • What is the Perspective Therapeutics, Inc. stock quote today?
    The Perspective Therapeutics, Inc. stock price is 2.7500 USD today.
  • How to buy Perspective Therapeutics, Inc. stock online?
    You can buy Perspective Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 2.1800 2.0500 2.1900 2.0500
Dec-3 2.0500 2.2100 2.2150 2.0500
Dec-4 2.2200 2.3900 2.4100 2.1700
Dec-5 2.3900 2.4000 2.4500 2.2850
Dec-8 2.4200 2.4000 2.4600 2.3000
Dec-9 2.4200 2.5200 2.5887 2.4000
Dec-10 2.5300 2.5500 2.5950 2.4450
Dec-11 2.5200 2.7000 2.7450 2.5200
Dec-12 2.7300 2.6700 2.8900 2.6500
Dec-15 2.7100 2.5400 2.8199 2.5300
Dec-16 2.5000 2.8400 2.9000 2.4500
Dec-17 2.8400 2.5900 2.8400 2.5650
Dec-18 2.6100 2.6700 2.7300 2.5650
Dec-19 2.6900 2.7500 2.8000 2.6650

Perspective Therapeutics, Inc. Earnings

Data Unavailable

Perspective Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.14 per share.

* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.